Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats.

Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats.

Our previous studies have found that bone-marrow-stromal cells (BMSC) therapy improves functional recovery after stroke in non-diabetic rats while increases brain hemorrhage and induces arteriosclerosis-like changes in type-one-diabetic (T1DM) rats. Niaspan treatment of stroke increases vascular sta...

Full description

Bibliographic Details
Main Authors: Tao Yan, Xinchun Ye, Michael Chopp, Alex Zacharek, Ruizhuo Ning, Poornima Venkat, Cynthia Roberts, Mei Lu, Jieli Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3841133?pdf=render

Internet

http://europepmc.org/articles/PMC3841133?pdf=render

Similar Items